Show simple item record

dc.contributor.authorJian, Le
dc.contributor.authorHuang, Y.
dc.contributor.editorKshanika Hirimburegama
dc.date.accessioned2017-01-30T13:02:24Z
dc.date.available2017-01-30T13:02:24Z
dc.date.created2012-11-25T20:00:15Z
dc.date.issued2012
dc.identifier.citationJian, Le and Huang, Yu. 2012. Does Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma? in K. Hirimburegama (ed), 44th APACPH Conference, Oct 14-17 2012. Colombo, Sri Lanka: Asia Pacific Academic Consortium for Public Health.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/27987
dc.publisherUniversity of Colombo
dc.titleDoes Chinese Medical Insurance System Affect Selection of Rituximab Therapy Among Patients with Non-Hodgkin Lymphoma?
dc.typeConference Paper
dcterms.source.titleAsia Pacific Journal of Public health
dcterms.source.seriesAsia Pacific Journal of Public health
dcterms.source.conference44th APACPH Conference
dcterms.source.conference-start-dateOct 13 2012
dcterms.source.conferencelocationSri Lanka
dcterms.source.placeColombo, Sri Lanka
curtin.department
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record